PL EN
  1. www.sciencepharma.pl
  2. Aktualności
  3. URPL: nformation of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 10, 2014 concerning amendment of fees related to marketing authorization of a medicinal product since January 1, 2015.

URPL: nformation of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 10, 2014 concerning amendment of fees related to marketing authorization of a medicinal product since January 1, 2015.

11.12.2014
This document is an information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 10, 2014 concerning amendment of fees related to marketing authorization of a medicinal product since January 1, 2015.
Źródło wiadomośći: http://www.urpl.gov.pl/aktualnosci/komunikat-prezesa-urzedu-z-dnia-9-grudnia-2014-r-w-sprawie-zmiany-od-dnia-1-stycznia-2015-r-wysokosci-oplat-zwiazanych-z-dopuszczeniem-do-obrotu-produ

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny